| Translocation (11;14)(q13;q32) without rearrangement of BCL1 oncogene in a case of chronic myeloproliferative syndrome. | None |
| Nuclear cyclin D1: an oncogenic driver in human cancer. | None |
| A rare BclI RFLP in the putative oncogene bcl-1 locus. | None |
| 3 UTR mediated regulation of the cyclin D1 proto-oncogene. | None |
| Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. | None |
| D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. | None |
| Targeting the degradation of cyclin D1 will help to eliminate oncogene addiction. | None |
| Anti-leukaemic effects of two extract types of Lactuca sativa correlate with the activation of Chk2, induction of p21, downregulation of cyclin D1 and acetylation of alpha-tubulin. | None |
| Cyclin K and cyclin D1b are oncogenic in myeloma cells. | None |
| Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. | None |
| The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. | None |
| Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation. | None |
| [An experimental study on the association of cyclin D1 oncoprotein with mutated p53 in progressive development of pulmonary tumors]. | None |
| Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1. | None |
| Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells. | None |
| Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers. | None |
| The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis. | None |
| Collectively, these data are the first to define the consequence of cyclin D1b expression on normal cellular function and present evidence for cyclin D1b as an oncogene. | None |
| Both cyclins D1a and D1b could promote cell proliferation, which might contribute to the potential oncogenic role of cyclin D1 variants during the precancerous cirrhotic stage of hepatocarcinogenesis | None |
| Kinase independent oncogenic cyclin D1. | None |